世界の組み換え非グリコシル化タンパク質市場2020:製造業者別、地域別、種類・用途別

【英語タイトル】Global Recombinant Non-glycosylated Protein Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20MY13281)・商品コード:GIR20MY13281
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年5月(※2024年版があります。お問い合わせください)
・ページ数:103
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、組み換え非グリコシル化タンパク質の世界市場を広く調査・分析し、今後の市場展望をまとめております。組み換え非グリコシル化タンパク質の種類別市場規模(インスリン、rHGH、インターフェロン)、用途別市場規模(腫瘍学、血液疾患)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Pfizer Inc、Celltrion Inc、Amgen Inc、Sandoz International GmbH、Roche Ltd、Teva Pharmaceuticals Industries Ltd、Dr.Reddy's Laboratories Ltd、Biocon Ltd、Samsung Bioepis
・地域別グローバル市場分析 2015年-2020年
・組み換え非グリコシル化タンパク質の北米市場(アメリカ、カナダ、メキシコ)
・組み換え非グリコシル化タンパク質のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・組み換え非グリコシル化タンパク質のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・組み換え非グリコシル化タンパク質の南米市場(ブラジル、アルゼンチン)
・組み換え非グリコシル化タンパク質の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:インスリン、rHGH、インターフェロン
・用途別分析:腫瘍学、血液疾患
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Recombinant Non-glycosylated Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Recombinant Non-glycosylated Protein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Recombinant Non-glycosylated Protein market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Recombinant Non-glycosylated Protein market has been segmented into
Insulin
rHGH
Interferon

By Application, Recombinant Non-glycosylated Protein has been segmented into:
Oncology
Blood Disorder

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Recombinant Non-glycosylated Protein market presented in the report. This section sheds light on the sales growth of different regional and country-level Recombinant Non-glycosylated Protein markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Recombinant Non-glycosylated Protein market.

The report offers in-depth assessment of the growth and other aspects of the Recombinant Non-glycosylated Protein market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Recombinant Non-glycosylated Protein Market Share Analysis
Recombinant Non-glycosylated Protein competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Recombinant Non-glycosylated Protein sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Recombinant Non-glycosylated Protein sales, revenue and market share for each player covered in this report.

The major players covered in Recombinant Non-glycosylated Protein are:
Pfizer Inc
Celltrion Inc
Amgen Inc
Sandoz International GmbH
Roche Ltd
Teva Pharmaceuticals Industries Ltd
Dr.Reddy’s Laboratories Ltd
Biocon Ltd
Samsung Bioepis

Among other players domestic and global, Recombinant Non-glycosylated Protein market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Non-glycosylated Protein product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Non-glycosylated Protein, with price, sales, revenue and global market share of Recombinant Non-glycosylated Protein in 2018 and 2019.
Chapter 3, the Recombinant Non-glycosylated Protein competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Non-glycosylated Protein breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Recombinant Non-glycosylated Protein market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Recombinant Non-glycosylated Protein sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Recombinant Non-glycosylated Protein Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Non-glycosylated Protein Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Insulin
1.2.3 rHGH
1.2.4 Interferon
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Non-glycosylated Protein Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Blood Disorder
1.4 Overview of Global Recombinant Non-glycosylated Protein Market
1.4.1 Global Recombinant Non-glycosylated Protein Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer Inc
2.1.1 Pfizer Inc Details
2.1.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer Inc SWOT Analysis
2.1.4 Pfizer Inc Product and Services
2.1.5 Pfizer Inc Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celltrion Inc
2.2.1 Celltrion Inc Details
2.2.2 Celltrion Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Celltrion Inc SWOT Analysis
2.2.4 Celltrion Inc Product and Services
2.2.5 Celltrion Inc Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen Inc
2.3.1 Amgen Inc Details
2.3.2 Amgen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen Inc SWOT Analysis
2.3.4 Amgen Inc Product and Services
2.3.5 Amgen Inc Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sandoz International GmbH
2.4.1 Sandoz International GmbH Details
2.4.2 Sandoz International GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sandoz International GmbH SWOT Analysis
2.4.4 Sandoz International GmbH Product and Services
2.4.5 Sandoz International GmbH Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche Ltd
2.5.1 Roche Ltd Details
2.5.2 Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche Ltd SWOT Analysis
2.5.4 Roche Ltd Product and Services
2.5.5 Roche Ltd Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pharmaceuticals Industries Ltd
2.6.1 Teva Pharmaceuticals Industries Ltd Details
2.6.2 Teva Pharmaceuticals Industries Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva Pharmaceuticals Industries Ltd SWOT Analysis
2.6.4 Teva Pharmaceuticals Industries Ltd Product and Services
2.6.5 Teva Pharmaceuticals Industries Ltd Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Dr.Reddy’s Laboratories Ltd
2.7.1 Dr.Reddy’s Laboratories Ltd Details
2.7.2 Dr.Reddy’s Laboratories Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Dr.Reddy’s Laboratories Ltd SWOT Analysis
2.7.4 Dr.Reddy’s Laboratories Ltd Product and Services
2.7.5 Dr.Reddy’s Laboratories Ltd Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Biocon Ltd
2.8.1 Biocon Ltd Details
2.8.2 Biocon Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Biocon Ltd SWOT Analysis
2.8.4 Biocon Ltd Product and Services
2.8.5 Biocon Ltd Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Samsung Bioepis
2.9.1 Samsung Bioepis Details
2.9.2 Samsung Bioepis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Samsung Bioepis SWOT Analysis
2.9.4 Samsung Bioepis Product and Services
2.9.5 Samsung Bioepis Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Recombinant Non-glycosylated Protein Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Recombinant Non-glycosylated Protein Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Non-glycosylated Protein Manufacturer Market Share in 2019
3.3.2 Top 6 Recombinant Non-glycosylated Protein Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Recombinant Non-glycosylated Protein Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Non-glycosylated Protein Sales and Market Share by Regions (2015-2020)
4.1.2 Global Recombinant Non-glycosylated Protein Revenue and Market Share by Regions (2015-2020)
4.2 North America Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
4.3 Europe Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
4.5 South America Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Recombinant Non-glycosylated Protein Sales, Revenue and Market Share by Country
5.1.1 North America Recombinant Non-glycosylated Protein Sales and Market Share by Country (2015-2020)
5.1.2 North America Recombinant Non-glycosylated Protein Revenue and Market Share by Country (2015-2020)
5.2 United States Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
5.3 Canada Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
5.4 Mexico Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Recombinant Non-glycosylated Protein Sales, Revenue and Market Share by Country
6.1.1 Europe Recombinant Non-glycosylated Protein Sales and Market Share by Country (2015-2020)
6.1.2 Europe Recombinant Non-glycosylated Protein Revenue and Market Share by Country (2015-2020)
6.2 Germany Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
6.3 UK Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
6.4 France Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
6.5 Russia Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
6.6 Italy Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Recombinant Non-glycosylated Protein Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Recombinant Non-glycosylated Protein Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Recombinant Non-glycosylated Protein Revenue and Market Share by Regions (2015-2020)
7.2 China Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
7.3 Japan Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
7.4 Korea Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
7.5 India Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
7.7 Australia Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Recombinant Non-glycosylated Protein Sales, Revenue and Market Share by Country
8.1.1 South America Recombinant Non-glycosylated Protein Sales and Market Share by Country (2015-2020)
8.1.2 South America Recombinant Non-glycosylated Protein Revenue and Market Share by Country (2015-2020)
8.2 Brazil Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
8.3 Argentina Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Recombinant Non-glycosylated Protein Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Recombinant Non-glycosylated Protein Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Recombinant Non-glycosylated Protein Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
9.3 Turkey Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
9.4 Egypt Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
9.5 South Africa Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Recombinant Non-glycosylated Protein Sales and Market Share by Type (2015-2020)
10.2 Global Recombinant Non-glycosylated Protein Revenue and Market Share by Type (2015-2020)
10.3 Global Recombinant Non-glycosylated Protein Price by Type (2015-2020)
11 Global Recombinant Non-glycosylated Protein Market Segment by Application
11.1 Global Recombinant Non-glycosylated Protein Sales Market Share by Application (2015-2020)
11.2 Global Recombinant Non-glycosylated Protein Revenue Market Share by Application (2015-2020)
11.3 Global Recombinant Non-glycosylated Protein Price by Application (2015-2020)
12 Market Forecast
12.1 Global Recombinant Non-glycosylated Protein Sales, Revenue and Growth Rate (2021-2025)
12.2 Recombinant Non-glycosylated Protein Market Forecast by Regions (2021-2025)
12.2.1 North America Recombinant Non-glycosylated Protein Market Forecast (2021-2025)
12.2.2 Europe Recombinant Non-glycosylated Protein Market Forecast (2021-2025)
12.2.3 Asia-Pacific Recombinant Non-glycosylated Protein Market Forecast (2021-2025)
12.2.4 South America Recombinant Non-glycosylated Protein Market Forecast (2021-2025)
12.2.5 Middle East & Africa Recombinant Non-glycosylated Protein Market Forecast (2021-2025)
12.3 Recombinant Non-glycosylated Protein Market Forecast by Type (2021-2025)
12.3.1 Global Recombinant Non-glycosylated Protein Sales Forecast by Type (2021-2025)
12.3.2 Global Recombinant Non-glycosylated Protein Market Share Forecast by Type (2021-2025)
12.4 Recombinant Non-glycosylated Protein Market Forecast by Application (2021-2025)
12.4.1 Global Recombinant Non-glycosylated Protein Sales Forecast by Application (2021-2025)
12.4.2 Global Recombinant Non-glycosylated Protein Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Recombinant Non-glycosylated Protein Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Recombinant Non-glycosylated Protein by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Recombinant Non-glycosylated Protein Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Inc Recombinant Non-glycosylated Protein Major Business
Table 9. Pfizer Inc Recombinant Non-glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 10. Pfizer Inc SWOT Analysis
Table 11. Pfizer Inc Recombinant Non-glycosylated Protein Product and Services
Table 12. Pfizer Inc Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Celltrion Inc Basic Information, Manufacturing Base and Competitors
Table 14. Celltrion Inc Recombinant Non-glycosylated Protein Major Business
Table 15. Celltrion Inc Recombinant Non-glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 16. Celltrion Inc SWOT Analysis
Table 17. Celltrion Inc Recombinant Non-glycosylated Protein Product and Services
Table 18. Celltrion Inc Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 20. Amgen Inc Recombinant Non-glycosylated Protein Major Business
Table 21. Amgen Inc Recombinant Non-glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 22. Amgen Inc SWOT Analysis
Table 23. Amgen Inc Recombinant Non-glycosylated Protein Product and Services
Table 24. Amgen Inc Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sandoz International GmbH Basic Information, Manufacturing Base and Competitors
Table 26. Sandoz International GmbH Recombinant Non-glycosylated Protein Major Business
Table 27. Sandoz International GmbH Recombinant Non-glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 28. Sandoz International GmbH SWOT Analysis
Table 29. Sandoz International GmbH Recombinant Non-glycosylated Protein Product and Services
Table 30. Sandoz International GmbH Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Roche Ltd Recombinant Non-glycosylated Protein Major Business
Table 33. Roche Ltd Recombinant Non-glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 34. Roche Ltd SWOT Analysis
Table 35. Roche Ltd Recombinant Non-glycosylated Protein Product and Services
Table 36. Roche Ltd Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Teva Pharmaceuticals Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 38. Teva Pharmaceuticals Industries Ltd Recombinant Non-glycosylated Protein Major Business
Table 39. Teva Pharmaceuticals Industries Ltd Recombinant Non-glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 40. Teva Pharmaceuticals Industries Ltd SWOT Analysis
Table 41. Teva Pharmaceuticals Industries Ltd Recombinant Non-glycosylated Protein Product and Services
Table 42. Teva Pharmaceuticals Industries Ltd Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Dr.Reddy's Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Dr.Reddy's Laboratories Ltd Recombinant Non-glycosylated Protein Major Business
Table 45. Dr.Reddy's Laboratories Ltd Recombinant Non-glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 46. Dr.Reddy's Laboratories Ltd SWOT Analysis
Table 47. Dr.Reddy's Laboratories Ltd Recombinant Non-glycosylated Protein Product and Services
Table 48. Dr.Reddy's Laboratories Ltd Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Biocon Ltd Basic Information, Manufacturing Base and Competitors
Table 50. Biocon Ltd Recombinant Non-glycosylated Protein Major Business
Table 51. Biocon Ltd Recombinant Non-glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 52. Biocon Ltd SWOT Analysis
Table 53. Biocon Ltd Recombinant Non-glycosylated Protein Product and Services
Table 54. Biocon Ltd Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 56. Samsung Bioepis Recombinant Non-glycosylated Protein Major Business
Table 57. Samsung Bioepis Recombinant Non-glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 58. Samsung Bioepis SWOT Analysis
Table 59. Samsung Bioepis Recombinant Non-glycosylated Protein Product and Services
Table 60. Samsung Bioepis Recombinant Non-glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Recombinant Non-glycosylated Protein Sales by Manufacturer (2018-2019) (K MT)
Table 62. Global Recombinant Non-glycosylated Protein Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Recombinant Non-glycosylated Protein Sales by Regions (2015-2020) (K MT)
Table 64. Global Recombinant Non-glycosylated Protein Sales Market Share by Regions (2015-2020)
Table 65. Global Recombinant Non-glycosylated Protein Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Recombinant Non-glycosylated Protein Sales by Countries (2015-2020) (K MT)
Table 67. North America Recombinant Non-glycosylated Protein Sales Market Share by Countries (2015-2020)
Table 68. North America Recombinant Non-glycosylated Protein Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Recombinant Non-glycosylated Protein Revenue Market Share by Countries (2015-2020)
Table 70. Europe Recombinant Non-glycosylated Protein Sales by Countries (2015-2020) (K MT)
Table 71. Europe Recombinant Non-glycosylated Protein Sales Market Share by Countries (2015-2020)
Table 72. Europe Recombinant Non-glycosylated Protein Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Recombinant Non-glycosylated Protein Sales by Regions (2015-2020) (K MT)
Table 74. Asia-Pacific Recombinant Non-glycosylated Protein Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Recombinant Non-glycosylated Protein Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Recombinant Non-glycosylated Protein Sales by Countries (2015-2020) (K MT)
Table 77. South America Recombinant Non-glycosylated Protein Sales Market Share by Countries (2015-2020)
Table 78. South America Recombinant Non-glycosylated Protein Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Recombinant Non-glycosylated Protein Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Recombinant Non-glycosylated Protein Sales by Countries (2015-2020) (K MT)
Table 81. Middle East & Africa Recombinant Non-glycosylated Protein Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Recombinant Non-glycosylated Protein Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Recombinant Non-glycosylated Protein Revenue Market Share by Countries (2015-2020)
Table 84. Global Recombinant Non-glycosylated Protein Sales by Type (2015-2020) (K MT)
Table 85. Global Recombinant Non-glycosylated Protein Sales Share by Type (2015-2020)
Table 86. Global Recombinant Non-glycosylated Protein Revenue by Type (2015-2020) (USD Million)
Table 87. Global Recombinant Non-glycosylated Protein Revenue Share by Type (2015-2020)
Table 88. Global Recombinant Non-glycosylated Protein Sales by Application (2015-2020) (K MT)
Table 89. Global Recombinant Non-glycosylated Protein Sales Share by Application (2015-2020)
Table 90. Global Recombinant Non-glycosylated Protein Sales Forecast by Regions (2021-2025) (K MT)
Table 91. Global Recombinant Non-glycosylated Protein Market Share Forecast by Regions (2021-2025)
Table 92. Global Recombinant Non-glycosylated Protein Sales Forecast by Type (2021-2025) (K MT)
Table 93. Global Recombinant Non-glycosylated Protein Market Share Forecast by Type (2021-2025)
Table 94. Global Recombinant Non-glycosylated Protein Sales Forecast by Application (2021-2025)
Table 95. Global Recombinant Non-glycosylated Protein Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Recombinant Non-glycosylated Protein Picture
Figure 2. Global Sales Market Share of Recombinant Non-glycosylated Protein by Type in 2019
Figure 3. Insulin Picture
Figure 4. rHGH Picture
Figure 5. Interferon Picture
Figure 6. Recombinant Non-glycosylated Protein Sales Market Share by Application in 2018
Figure 7. Oncology Picture
Figure 8. Blood Disorder Picture
Figure 9. Global Recombinant Non-glycosylated Protein Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Recombinant Non-glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Recombinant Non-glycosylated Protein Sales Market Share by Manufacturer in 2019
Figure 30. Global Recombinant Non-glycosylated Protein Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Recombinant Non-glycosylated Protein Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Recombinant Non-glycosylated Protein Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 35. Global Recombinant Non-glycosylated Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Recombinant Non-glycosylated Protein Revenue Market Share by Regions (2015-2020)
Figure 37. Global Recombinant Non-glycosylated Protein Revenue Market Share by Regions in 2018
Figure 38. North America Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
Figure 39. Europe Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
Figure 41. South America Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020)
Figure 43. North America Recombinant Non-glycosylated Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Recombinant Non-glycosylated Protein Sales Market Share by Countries (2015-2020)
Figure 45. North America Recombinant Non-glycosylated Protein Sales Market Share by Countries in 2018
Figure 46. North America Recombinant Non-glycosylated Protein Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Recombinant Non-glycosylated Protein Revenue Market Share by Countries in 2018
Figure 48. United States Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 49. Canada Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Mexico Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Europe Recombinant Non-glycosylated Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Recombinant Non-glycosylated Protein Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Recombinant Non-glycosylated Protein Revenue Market Share by Countries in 2019
Figure 54. Germany Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 55. UK Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 56. France Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Russia Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Italy Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Asia-Pacific Recombinant Non-glycosylated Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Recombinant Non-glycosylated Protein Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Recombinant Non-glycosylated Protein Revenue Market Share by Regions 2019
Figure 62. China Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Japan Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Korea Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 65. India Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Southeast Asia Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 67. South America Recombinant Non-glycosylated Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Recombinant Non-glycosylated Protein Sales Market Share by Countries in 2019
Figure 69. South America Recombinant Non-glycosylated Protein Revenue Market Share by Countries in 2019
Figure 70. Brazil Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Argentina Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Middle East and Africa Recombinant Non-glycosylated Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Recombinant Non-glycosylated Protein Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Recombinant Non-glycosylated Protein Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Recombinant Non-glycosylated Protein Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Egypt Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Turkey Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 79. South Africa Recombinant Non-glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Global Recombinant Non-glycosylated Protein Sales and Growth Rate (2021-2025) (K MT)
Figure 81. Global Recombinant Non-glycosylated Protein Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Recombinant Non-glycosylated Protein Market Forecast (2021-2025) (K MT)
Figure 83. Europe Sales Recombinant Non-glycosylated Protein Market Forecast (2021-2025) (K MT)
Figure 84. Asia-Pacific Sales Recombinant Non-glycosylated Protein Market Forecast (2021-2025) (K MT)
Figure 85. South America Sales Recombinant Non-glycosylated Protein Market Forecast (2021-2025) (K MT)
Figure 86. Middle East & Africa Sales Recombinant Non-glycosylated Protein Market Forecast (2021-2025) (K MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Pfizer Inc、Celltrion Inc、Amgen Inc、Sandoz International GmbH、Roche Ltd、Teva Pharmaceuticals Industries Ltd、Dr.Reddy's Laboratories Ltd、Biocon Ltd、Samsung Bioepis

★調査レポート[世界の組み換え非グリコシル化タンパク質市場2020:製造業者別、地域別、種類・用途別] (コード:GIR20MY13281)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の組み換え非グリコシル化タンパク質市場2020:製造業者別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆